Drugs commonly used to treat high blood pressure, called angiotensin converting enzyme (ACE) inhibitors, could be linked to an increased risk of lung cancer, according to a new BMJ study. - BHF
ACE Inhibitors and Lung Cancer | Neil Kurtzman
Cancers | Free Full-Text | Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study
ACE Inhibitors Linked to Higher Lung Cancer Risk
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports
Our ACE in the HOLE: Justifying the Use of Angiotensin-converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy | Anticancer Research
What are ACE inhibitor blood pressure tablets, what are the side effects and can they cause cancer? | The Sun
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment: Molecular Therapy - Methods & Clinical Development
Cancers | Free Full-Text | SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
Chronic high-dose angiotensin receptor blocker use associated with cancer risk
The People's Pharmacy
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer | Circulation: Cardiovascular Quality and Outcomes
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer | Circulation: Cardiovascular Quality and Outcomes
ACE Inhibitors Linked to Higher Lung Cancer Risk - MEDizzy
ACE Inhibitors | SpringerLink
Lung cancer risk could be higher due to common blood pressure pills, research finds | Daily Mail Online
ACE Inhibitors | Underpaidnurse's Blog
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study | The BMJ
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy | Science Translational Medicine
Frontiers | Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions
Medscape on Twitter: "An association with an increased risk of lung cancer resulted in ACE Inhibitors being the top #ClinicalTrend on Medscape this week. https://t.co/6gGkykY3Ui https://t.co/Xbz3ndwXP5" / Twitter
Cigarette smoke triggers increased ACE-2 expression in the lung | Immunopaedia
PDF) Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung ...
Cureus | Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study | Article
